IPRsonline.org

General texts on intellectual property rights

IPRs, biodiversity loss, access & benefit sharing, prior informed consent

Intellectual property, trade and competition

Intellectual property and folklore, music and entertainment

Intellectual property and public education

Intellectual property and information and communication technologies

Intellectual property and the protection of biodiversity

Intellectual property and agriculture, food and nutrition

Intellectual property and access to medicines in developing countries

Intellectual property and foreign direct investment

Human rights aspects of intellectual property

Intellectual property and technology transfer: help or hindrance?

Intellectual property and the knowledge, innovations and practices of indigenous peoples and local communities

TRIPS, implementation and Review

ICTSD dialogues on trade, IPRs and sustainable development

Selected new stories published in BRIDGES

Discussion papers and BRIDGES articles on IPRs, trade and sustainable development

Resource Book, Policy Paper, Case Studies and Research Tools

About the UNCTAD-ICTSD project on IPRs

Related UNCTAD and ICTSD activities in this area

Setting an agenda for IP negotiations in the next five years

WIPO: Institutional functioning and relevant developments

WTO Members' Submissions on IPRs

Advancing the reform agenda

Policy Options for Assuring Affordable Access to Essential Medicines

Preserving Public Goods in health, education and learning

Intellectual Property and Free Trade Agreements

Intellectual Property and Geographical Indications

POLICY OPTIONS FOR ASSURING AFFORDABLE ACCESS TO ESSENTIAL MEDICINES
The Bellagio Series on Development and Intellectual Property Policy

At the Rockefeller Foundation's Bellagio Study and Conference Center on Lake Como in Northern Italy,
12 - 16 October 2004

Tuesday 12 October

Welcoming of Participants

Wednesday 13 October

Morning Session: 9:00 - 10:30

Latest developments and trends on IP, health and pharmaceutical data exclusivity
Resource person: Frederick Abbott
Commentator on data exclusivity: Meir Pugatch
Discussion

Morning Session: 10.30 – 13:00

Module I: Explore the effects of current efforts to develop Public Private Partnerships (PPP) as to engage in wider R&D for neglected diseases. The case of HIV, Malaria or Tuberculosis.
Resource person: Roy Widdus
Commentators: Cathy Garner, Gilles Forte and Charles Gardner
Discussion

Afternoon Session: 14:00– 18:00

Module II: Suggesting approaches to facilitate access to medicines through compulsory licensing.
Resource person: Jamie Love
Commentators: Besher N’Daw, Martin Watson and David Vivas-Eugui
Discussion

Thursday 14 October

Morning Session: 9:00 – 13:00

Module III: Creating and promoting domestic drug manufacturing capacities: legal and economic feasibility assessment.
Resource persons: Joan Rovira
Commentators: Rodrigo Salinas, Padmashree Gehl Sampath, Jake Werksman and Muhammadul Haque
Discussion

Afternoon Session: 14:00 – 18:00

Module IV: Competition policy as a tool to address public health concerns. The case of South Africa and Brazil.
Resource persons: Jonathan Berger and Barbara Rosenberg
Commentators: Sisule Musungu, Jamie Love and Shamnad Basheer
Discussion

Friday 15 October

Morning Session: 9:00 – 13:00

Working Groups:

Promoting PPP for R&D in neglected diseases

Facilitating access to medicines through compulsory licensing

Seeking ways for creating and promoting of domestic drug manufacturing capacities

How to strengthen competition policy and institutions as to moderate potential anticompetitive effects of IP in the health field

Afternoon Session: 14:00 – 18:00

Plenary meeting:

Presentation of conclusions of Working Groups

General discussion on priorities and feasibility of policy actions and research agenda proposed by the Working Groups

Adoption of conclusions of the dialogue

Saturday 16 October

Departure of Participants